Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 Infections
CARLSBAD, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc., a clinical-stage biopharmaceutical company…
Zynova Tech Launches the Title Industry’s First Automated Workshare Platform for Compliant, Multi-Jurisdictional Order Flow
Masar Destination Achieves LEED for Communities Gold Certification
Sir Ivan Releases “Love Is The Piece”